Galectin Therapeutics (GALT) Net Cash Flow (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Galectin Therapeutics | 165.77 Mn | 151.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -158.81% |
| Dec 31, 2025 | 378.45% |
| Sep 30, 2025 | -134.81% |
| Jun 30, 2025 | 182.34% |
| Mar 31, 2025 | 35.47% |
| Dec 31, 2024 | -928.65% |
| Sep 30, 2024 | -29.61% |
| Jun 30, 2024 | 197.05% |
| Mar 31, 2024 | -140.00% |
| Dec 31, 2023 | 119.66% |
| Sep 30, 2023 | 1,334.73% |
| Jun 30, 2023 | 121.06% |
| Mar 31, 2023 | -128.72% |
| Dec 31, 2022 | 133.08% |
| Sep 30, 2022 | -12.37% |
| Jun 30, 2022 | 7.63% |
| Mar 31, 2022 | -363.85% |
| Dec 31, 2021 | -39.06% |
| Sep 30, 2021 | -53.85% |
| Jun 30, 2021 | 269.82% |
| Mar 31, 2021 | -17.88% |
| Dec 31, 2020 | 34.07% |
| Sep 30, 2020 | -220.78% |
| Jun 30, 2020 | 38.34% |
| Mar 31, 2020 | -45.33% |
| Dec 31, 2019 | -67.47% |
| Sep 30, 2019 | -103.79% |
| Jun 30, 2019 | 3,618.42% |
| Mar 31, 2019 | 31.97% |
| Dec 31, 2018 | -421.61% |
| Sep 30, 2018 | -105.55% |
| Jun 30, 2018 | 596.15% |
| Mar 31, 2018 | 123.94% |
| Dec 31, 2017 | -80.04% |
| Sep 30, 2017 | 51.98% |
| Jun 30, 2017 | -162.92% |
| Mar 31, 2017 | -146.48% |
| Dec 31, 2016 | 64.15% |
| Sep 30, 2016 | 57.83% |
| Jun 30, 2016 | -32.09% |
| Mar 31, 2016 | -177.09% |
| Dec 31, 2015 | 189.77% |
| Sep 30, 2015 | -68.83% |
| Jun 30, 2015 | -1,451.58% |
| Mar 31, 2015 | 110.66% |
| Dec 31, 2014 | 35.66% |
| Sep 30, 2014 | -48.41% |
| Jun 30, 2014 | -108.32% |
| Mar 31, 2014 | 3,272.74% |
| Dec 31, 2013 | -83.23% |
| Sep 30, 2013 | 340.54% |
| Jun 30, 2013 | 18.20% |
| Mar 31, 2013 | -38.41% |
| Dec 31, 2012 | 18.47% |
| Sep 30, 2012 | 4.81% |
| Jun 30, 2012 | -124.49% |
| Mar 31, 2012 | 676.41% |
| Dec 31, 2011 | -3,767.50% |
| Sep 30, 2011 | -103.84% |
| Jun 30, 2011 | -1.51% |
| Mar 31, 2011 | -65.65% |
| Dec 31, 2010 | 6,379.59% |